Occupational Activity
Samsung Bioepis Sees 107% Sales Growth in Q2, Driven by Biosimilars
Samsung Bioepis, biosimilars, sales growth, Q2, operating profit, market share
Biopharma Layoff Tracker 2024: Industry-Wide Job Cuts Continue
Biopharma, Layoffs, Job Cuts, Industry Tracker, 2024
Layoffs Persist, GLP-1s Launch for Weight Loss in China
GLP-1, weight loss, China, Novo Nordisk, Eli Lilly, layoffs, biopharma industry, semaglutide, tirzepatide, obesity, diabetes
Fierce Biotech Layoff Tracker 2024: Industry-Wide Job Cuts Continue
Biotech Layoffs, 2024, MEI Pharma, Rapt Therapeutics, Industry Cuts
MEI Pharma’s Leadership Shakeup: CEO and Medical Head Step Down Amidst Wind-Down Considerations
MEI Pharma, wind down, CEO, medical head, strategic alternatives
Biopharma Layoff Tracker 2024: Thousands of Jobs Cut Across Industry Giants
Biopharma Layoffs, 2024, Industry Giants, Job Cuts, Restructuring, Cost Savings
Cardurion Pharmaceuticals Raises $260M in Series B Funding to Challenge Statin-Dominated Cardiovascular Market
Cardurion Pharmaceuticals, Series B Funding, Cardiovascular, Statins, Biotech, Bain Capital, Ascenta Capital, NEA, GV, Fidelity Management & Research Company, Millennium Management, Farallon Capital Management, Invus, Blue Owl Healthcare Opportunities, Delos Capital, Digitalis Ventures
How the world’s biggest pharma and biotech companies paid their typical worker in 2023
Midline (qualifier value), Wages, Pharma, Worker
How the world’s biggest pharma and biotech companies paid their typical worker in 2023
Dosage Forms, Industry, world ‘s, Worker, 2023
Pfizer Faces Key R&D Challenges as Chief Scientific Officer Mikael Dolsten Departs
Pfizer, Mikael Dolsten, Chief Scientific Officer, R&D Challenges, Biopharma Industry